Stephanie Herron was named chief development officer of Stand Up To Cancer. In this newly created position, she will be responsible for the growth and development of SU2C’s fundraising strategy, focusing on major gifts, corporate philanthropy, digital engagement, and innovation.
Nobel laureate Phillip A. Sharp, who has chaired the Stand Up To Cancer scientific advisory committee since SU2C launched in 2008 is transitioning to emeritus status at the organization.
